REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Designated Organic Active Ingredient Containing (doai) > Heterocyclic Carbon Compounds Containing A Hetero Ring Having Chalcogen (i.e., O,s,se Or Te) Or Nitrogen As The Only Ring Hetero Atoms Doai > Hetero Ring Is Six-membered And Includes At Least Nitrogen And Sulfur As Ring Members > Three Or More Ring Hetero Atoms In The Six-membered Hetero Ring > Polycyclo Ring System Having The Six-membered Hetero Ring As One Of The Cyclos > 1,2,4 - Benzothiadiazine - 1,1 - Dioxides (including Hydrogenated) 1,2,4 - Benzothiadiazine - 1,1 - Dioxides (including Hydrogenated)1,2,4 - Benzothiadiazine - 1,1 - Dioxides (including Hydrogenated) patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.12/28/06 - 20060293311 - Compositions and methods for inhibition of the jak pathway The invention encompasses compounds having formula I-V and the compositions and methods using these compounds in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK3, may be therapeutically useful. ... 12/21/06 - 20060287300 - Anti-infective agents are hepatitis C (HCV) polymerase inhibitors. Also disclosed are compositions and methods for inhibiting hepatitis C (HCV) polymerase, processes for making the compounds, and synthetic intermediates employed in the processes. ... 08/24/06 - 20060189603 - Nitric oxide enhancing diuretic compounds, compositions and methods of use The invention describes novel compositions and kits comprising at least one nitric oxide enhancing diuretic compound, or pharmaceutically acceptable salts thereof, and, optionally, at least one nitric oxide enhancing compound and/or at least one therapeutic agent. The invention also provides methods for (a) treating conditions resulting from excessive water and/or ... 06/08/06 - 20060122174 - Antiviral treatment A diuretic, e.g. loop diuretic or thiazide, or a sulphylurea is useful in the treatment of DNA viral infections. ... 06/08/06 - 20060122173 - Il-8 receptor antagonists This invention relates to novel compounds of Formula (I) to (VII), and compositions thereof, useful in the treatment of disease states mediated by the chemokine, Interleukin-8 (IL-8). ... 05/04/06 - 20060094712 - New benzothiadiazine compounds R3 represents unsubstituted or substituted aryl, their isomers, and also addition salts thereof. and medicinal products containing the same which are useful in treating or preventing disorders associated with AMPA flux. ... 12/01/05 - 20050267103 - Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders The present invention relates to methods and compositions for treating neuropathic pain and neuropsychiatric disorders by administering agents that are effective in reducing the effective amount, inactivating, and/or inhibiting the activity of a Na+—K+-2Cl− (NKCC) cotransporter. In certain embodiments, the Na+—K+-2Cl− co-transporter is NKCC1. ... 11/24/05 - 20050261284 - Diazinopyrimidines X2 is a bond, O, NR6, S or CH2, where R6 is hydrogen or alkyl. ... 10/27/05 - 20050239775 - Substituted-3-indolyl-4-piperidino-alkyl heterocycles for the treatment of depression and R1-9 are as defined herein, a composition containing this compound and methods for treating disorders of the serotonin-affected neurological systems utilizing such a compound or composition. ... 07/28/05 - 20050165008 - Fluorinated benzothiadiazine compounds R3 to R6, which may be the same or different, each represent an atom or group selected from hydrogen, halogen, nitro, cyano, alkylsulphonyl, hydroxy, alkoxy, optionally substituted alkyl and optionally substituted amino, its optical isomers when they exist, and also their addition salts with a pharmaceutically acceptable acid or base. ... 07/21/05 - 20050159410 - Treatment solution and method for preventing posterior capsular opacification by selectively inducing detachment and/or death of lens epithelial cells A treatment solution used to prevent posterior capsular opacification is applied or introduced into the lens capsular bag before, during, or after cataract surgery. The treatment solution may also be applied to an intraocular lens prior to surgery. The treatment solution comprises an ion transport mechanism interference agent, which either ... 06/09/05 - 20050124607 - 5-substituted quinazolinone compounds useful as alpha 1a/b adrenergic receptor antagonists wherein Q is a monocyclic or bicyclic optionally-substituted heterocyclic ring as defined herein; Z is —C(═O)— or —S(═O)2—; R and R′ are lower alkyl; R5 is halogen, cyano, hydroxy, —R6, or —OR6; and R6 is alkyl, substituted alkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, cycloalkyl, substituted cycloalkyl, heterocyclo, or substituted ... ### FreshPatents.com Support |